Search alternatives:
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
421
-
422
Chloroquine and hydroxychloroquine decrease CXCL12-mediated proliferation in pancreatic cancer cell lines.
Published 2013“…(D) Pretreatment with chloroquine and hydroxychloroquine also triggered apoptosis and decreased CXCL12-mediated apoptosis in PANC-1 cells. …”
-
423
-
424
-
425
-
426
-
427
HRMECs treated with 3-Deazaneplanocin A (DZNep) chemical inhibitor demonstrated increased miR-200b and decreased VEGF expression.
Published 2015“…[NG = 5mM D-glucose, HG = 25mM D-glucose, NG+DMSO = 5mM D-glucose + 0.05% DMSO, HG+DMSO = 25mM D-glucose + 0.05% DMSO, NG+DZNEP = 5mM D-glucose + 5μM DZNep, HG+DZNEP = 25mM + 5μM DZNep; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to β-actin for VEGF and U6 for miR-200b, expressed as a fold change of NG].…”
-
428
Surviving female mice born from DIO or lean dams display a small decrease in rate of intake.
Published 2018“…WD offspring had higher body mass at time of wean but body weights were rapidly normalized over the monitoring period (a). There were no differences meal size (a) but slight decrease in rate of intake between groups (b). …”
-
429
-
430
The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 6
Published 2017“…<p>The effects of GSK360A on <b>(A)</b> mNSS, <b>(B)</b> beam balance, <b>(C)</b> foot fault and <b>(D)</b> hind limb performance at 5 hours, 1 day, 1 week and 3 weeks after stroke. …”
-
431
-
432
-
433
-
434
-
435
-
436
-
437
-
438
-
439
-
440